[{"address1": "331 Oyster Point Boulevard", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 481 6770", "website": "https://pliantrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of av\u00df6 and av\u00df1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of av\u00df1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins av\u00df8 and av\u00df1 for the treatment of solid tumors; and PLN-101325, a phase 1-ready program for treatment of the muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 171, "companyOfficers": [{"maxAge": 1, "name": "Dr. Bernard  Coulie M.B.A., M.D., Ph.D.", "age": 58, "title": "President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 996968, "exercisedValue": 5432729, "unexercisedValue": 7282323}, {"maxAge": 1, "name": "Dr. Keith Lamont Cummings M.B.A., M.D.", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 684144, "exercisedValue": 1694253, "unexercisedValue": 2111570}, {"maxAge": 1, "name": "Dr. Eric A. Lefebvre M.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 734411, "exercisedValue": 0, "unexercisedValue": 2070744}, {"maxAge": 1, "name": "Dr. Rik  Derynck Ph.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dean  Sheppard M.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bill  DeGrado Ph.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hal  Chapman M.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Delphine  Imbert Ph.D.", "title": "Chief Technical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher S. Keenan", "title": "Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shuguang  Zhu Ph.D.", "title": "Senior Vice President of Chemistry, Manufacturing & Controls", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.57, "open": 1.54, "dayLow": 1.45, "dayHigh": 1.55, "regularMarketPreviousClose": 1.57, "regularMarketOpen": 1.54, "regularMarketDayLow": 1.45, "regularMarketDayHigh": 1.55, "payoutRatio": 0.0, "beta": 1.47, "forwardPE": -0.3631841, "volume": 653192, "regularMarketVolume": 653192, "averageVolume": 2719412, "averageVolume10days": 812610, "averageDailyVolume10Day": 812610, "bid": 1.42, "ask": 1.49, "bidSize": 5, "askSize": 5, "marketCap": 96376504, "fiftyTwoWeekLow": 1.1, "fiftyTwoWeekHigh": 16.52, "fiftyDayAverage": 1.8333, "twoHundredDayAverage": 9.9971, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -206127008, "profitMargins": 0.0, "floatShares": 50199674, "sharesOutstanding": 61386300, "sharesShort": 5089401, "sharesShortPriorMonth": 3978061, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0829, "heldPercentInsiders": 0.03264, "heldPercentInstitutions": 1.16757, "shortRatio": 2.99, "shortPercentOfFloat": 0.0849, "impliedSharesOutstanding": 66011300, "bookValue": 4.996, "priceToBook": 0.2922338, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -210304000, "trailingEps": -3.47, "forwardEps": -4.02, "enterpriseToEbitda": 0.911, "52WeekChange": -0.879239, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 1.46, "targetHighPrice": 47.0, "targetLowPrice": 1.5, "targetMeanPrice": 10.0625, "targetMedianPrice": 3.0, "recommendationKey": "none", "numberOfAnalystOpinions": 8, "totalCash": 355724000, "totalCashPerShare": 5.809, "ebitda": -226240000, "totalDebt": 60192000, "quickRatio": 10.778, "currentRatio": 10.906, "debtToEquity": 19.795, "returnOnAssets": -0.314, "returnOnEquity": -0.54087, "freeCashflow": -98528128, "operatingCashflow": -155503008, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Pliant Therapeutics, Inc.", "longName": "Pliant Therapeutics, Inc.", "exchange": "NMS", "messageBoardId": "finmb_325980525", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -7.00637, "regularMarketPrice": 1.46, "corporateActions": [], "postMarketTime": 1745624613, "regularMarketTime": 1745611201, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1591191000000, "postMarketChangePercent": -3.69863, "earningsTimestamp": 1741035600, "earningsTimestampStart": 1746442740, "earningsTimestampEnd": 1746792000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.47, "epsForward": -4.02, "epsCurrentYear": -2.29183, "priceEpsCurrentYear": -0.6370455, "fiftyDayAverageChange": -0.37329996, "fiftyDayAverageChangePercent": -0.20362186, "twoHundredDayAverageChange": -8.5371, "twoHundredDayAverageChangePercent": -0.85395765, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-06-03", "marketState": "CLOSED", "postMarketPrice": 1.406, "postMarketChange": -0.054, "regularMarketChange": -0.110000014, "regularMarketDayRange": "1.45 - 1.55", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2719412, "fiftyTwoWeekLowChange": 0.36, "fiftyTwoWeekLowChangePercent": 0.32727274, "fiftyTwoWeekRange": "1.1 - 16.52", "fiftyTwoWeekHighChange": -15.06, "fiftyTwoWeekHighChangePercent": -0.9116223, "fiftyTwoWeekChangePercent": -87.923904, "displayName": "Pliant Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]